Success of Covid Antiviral Pills Hinges on Access to Speedy and Accurate Tests
By JoNel Aleccia – Within a few weeks, perhaps before many Americans finish decorating for the holidays, the U.S. could have access to a new antiviral pill from Merck expected to alter the deadly trajectory of the covid-19 pandemic — with a second option from Pfizer to follow shortly after.
Read More